June 16, 2026
According to Shivani Zoting, who specializes in healthcare market diagnostics and med-tech industry analysis, with 5+ years of experience in market research and medical production research, laboratory tools, and healthcare devices indicate significan...
April 24, 2026
Sterile Drug Product Testing Market ( By Test Type: Sterility Testing, Endotoxin Testing, Particulate Matter Testing, Container Closure Integrity Testing, Bioburden Testing; By Product and Service Type: Instruments, Reagents & Kits, Testing ...
June 08, 2026
According to Rohan Patil, who specializes in healthcare and life sciences market intelligence with 5+ years of experience in market research and industry analysis, the U.S. Drug Screening Market is set for steady expansion, rising from USD 2.90 billi...
April 21, 2026
Projections indicate that, innovative drug CRO industry is projected to rise from USD 56.56 billion in 2025 to USD 96.06 billion by 2035, reflecting a CAGR of 5.44% over the next decade. The growing demand for personalized medicines and technological...
April 21, 2026
Market insights predict, the topical antibiotic drug industry is expected to grow from USD 5.65 billion in 2024 to USD 9.59 billion by 2034, driven by a CAGR of 5.45%. The market is growing globally due to increasing skin infections, rising antimicro...
April 21, 2026
Market insights predict, the compound management industry is expected to grow from USD 492.14 million in 2024 to USD 1899.41 million by 2034, driven by a CAGR of 14.51%. The compound management market is expanding due to growing outsourcing tre...
February 09, 2026
The global GMP drug substance market was USD 2.71 billion in 2025 and is projected to reach USD 4.91 billion by 2035 at a CAGR of 6.14%. Key segments include viral vectors, cell-based therapies, oligonucleotides, and biologics. North America leads,...
April 21, 2026
Projections indicate that, small nucleic acid drug industry is projected to rise from USD 5.94 billion in 2024 to USD 33.28 billion by 2034, reflecting a CAGR of 18.84% over the next decade. The rising prevalence of chronic disorders and the growing ...
April 21, 2026
According to forecasts, the global drug-induced dyskinesia market will grow from USD 418 million in 2024 to USD 627.5 million by 2034, with an expected CAGR of 4.34%. The market is growing due to the rising prevalence of Parkinsons disease and increa...
April 21, 2026
The robotics in drug discovery market is growing due to rising demand for faster, accurate research and reduced human error. Automation accelerated high-throughput screening and improved efficacy in early-stage drug development....
April 21, 2026
Based on market forecasts, the pemphigus vulgaris sector will expand from USD 530.43 million in 2025 to USD 1171.93 million by 2035, experiencing a CAGR of 8.25%. The pemphigus vulgaris market is growing due to increasing clinical trials aimed at dev...
April 21, 2026
Market insights predict the global drug-loaded fat emulsion industry will increase from USD 2.34 billion in 2024 to USD 7.25 billion by 2034, achieving a CAGR of 12.04%. The principal advantages of these delivery systems, including versatile administ...
April 21, 2026
According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to...
July 24, 2026
According to Payal Rabde, who specializes in devices designed to administer medications safely, accurately, and efficiently through various routes of delivery, biologics, vaccines, insulin, oncology drugs, and other specialty therapeutics, with 4+ ye...
April 21, 2026
Market insights predict the global blood-brain barrier industry will increase from USD 6.03 billion in 2025 to USD 55.45 billion by 2035, achieving a CAGR of 24.85%.The rising prevalence of neurological disorders and advances in neuroscience technolo...
April 21, 2026
The compounded topical drug market is growing due to increasing skin disorders affecting 1.8 billion people, personalized medicine demands, and drug shortages. Compounding allows for tailored medications without allergens. Key trends include Medisca'...
April 21, 2026
The Hair Treatment Drug Market is growing as hair loss, driven by factors like hormonal imbalances, immune disorders, and pollution, impacts many. Treatments include OTC options like biotin, zinc, and tea tree oil, while prescribed drugs like minoxid...
April 21, 2026
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
May 22, 2026
Small Molecules Market (By Product Lifecycle: Patented/Innovator Small-Molecule Brands, Generics, OTC/Non-prescription; By Therapeutic Area: Oncology, Cardiometabolic, CNS/Psychiatry & Neurology, Infectious Diseases, Respiratory & Allergy, Ga...
April 21, 2026
Based on market forecasts, the Europe life science market, projected at USD 26.32 billion in 2024, is expected to reach USD 78.90 billion by 2034, growing at a CAGR of 11.61% over the forecast period. The growing public health concerns, significant s...
April 21, 2026
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America ...
February 24, 2026
Market insights predict the global antibody drug conjugate (ADC) industry will increase from USD 13.51 billion in 2025 to USD 32.66 billion by 2035, achieving a CAGR of 9.23%. The rising number of cancer cases and the rising need for safe, efficient ...
June 18, 2026
Rohan Patil, an expert in pharmaceuticals with over five years of experience in market research and industry analysis, reports that extensive analysis has shown that there are substantial growth possibilities available within the Animal Drug Compound...
July 27, 2026
According to Payal Rabde, who specializes in identifying new therapeutic used for existing approved or investigational drugs, reducing drug development time, cost, and clinical risks, and accelerating treatment development for rare, chronic and infec...
April 21, 2026
The peptide-based weight loss medication market is expanding due to a growing health-conscious population as well as rising muscle-preserving weight loss medications. North America led the market due to the presence of a well-developed healthcare sec...
April 21, 2026
According to market projections, the connected drug delivery devices sector is expected to grow from USD 9.18 billion in 2025 to USD 75.41 billion by 2035, reflecting a CAGR of 23.44%. The rising prevalence of chronic disorders and the growing demand...
January 27, 2026
The computer vision for drug manufacturing market is growing due to its majorly application in pharmaceuticals, which leverages deep learning technology for quality control, visual inspection, and procedure automation, and also enhances pharmaceutica...
July 31, 2026
According to Payal Rabde, who specializes in pharmaceuticals, biotechnology, and rare disease market research, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the orpha...
April 21, 2026
According to market projections, the protein labeling sector is expected to grow from USD 2.67 billion in 2024 to USD 6.02 billion by 2034, reflecting a CAGR of 8.48%. Protein labeling is used in research and diagnosis of various diseases, which driv...
May 21, 2026
Pharmaceutical CXO Market (By Service Type: Contract Research Organization, Clinical Trial Services, Regulatory Affairs Services, Medical Writing & Data Management, Contract Development and Manufacturing Organization, API Manufacturing, Drug Prod...
April 21, 2026
Market insights predict the global drug reference apps industry will increase from USD 1.47 billion in 2025 to USD 3.55 billion by 2035, achieving a CAGR of 9.20%. The drug reference apps market is growing due to digital transformation. North America...
April 21, 2026
Projections indicate that, mice model industry is projected to rise from USD 1.57 billion in 2024 to USD 4.1 billion by 2034, reflecting a CAGR of 10.04% over the next decade. The mice model market is rising strongly due to the growing research ...
April 21, 2026
The temperature-sensitive drug market is expanding due to increasing vaccination as well as growing demand for biosimilars. North America led the market due to the growing use of biologics....
April 21, 2026
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for...
May 29, 2026
Dental Drug Market (By Product Type/Formulation: Topical gels/pastes, Varnishes & paints, Mouthrinses & oral washes, Injectable solutions, Local delivery systems, Systemic oral antibiotics/analgesics for dental indications; By Therapeutic Cla...
July 24, 2026
Market insights predict, the antibodies drug industry is expected to grow from USD 272.3 billion in 2026 to USD 759.36 billion by 2035, driven by a CAGR of 10.8%. The increase in the production of monoclonal antibodies is leading to higher demand for...
February 10, 2026
Based on our research, the drug product development service market was valued at USD 340.04 million in 2025 and is projected to reach USD 350.38 million in 2026, expanding further to USD 458.76 million by 2035 at a CAGR of 3.04%....
April 21, 2026
Market insights predict the global drug designing tools industry will increase from USD 3.4 billion in 2024 to USD 7.86 billion by 2034, achieving a CAGR of 8.73%. The drug designing tools market is growing due to it is an inventive method of finding...
July 08, 2026
According to market statistics data, the comparator drug sourcing industry is projected to grow from US$ 1.39 billion in 2026 to US$ 2.24 billion by 2035, driven by rising clinical trials and R&D. Central sourcing, AI integration, and expanding g...
April 21, 2026
Based on market forecasts, the global lead optimization services in drug discovery market, projected at USD 4.26 billion in 2024, is expected to reach USD 10.26 billion by 2034, growing at a CAGR of 9.23% over the forecast period. The lead optimizati...
July 20, 2026
According to projections, the global topical drug delivery market, valued at USD 268.96 billion in 2025, is anticipated to reach USD 622.85 billion by 2035, growing at a CAGR of 8.76% over the next decade. A widespread increase in cases of diverse sk...
April 21, 2026
According to market projections, the global needle free drug delivery devices market, valued at USD 14.24 billion in 2024, is anticipated to reach USD 29.54 billion by 2034, growing at a CAGR of 7.54% over the next decade. The needle free drug delive...
July 13, 2026
According to Shivani Zoting, who specializes in healthcare diagnostics and life sciences markets, with 5+ years of experience in market research and industry analysis, this research shows that the global drug screening market is projected to grow fro...
June 23, 2026
According to Rohan Patil, who specializes in Healthcare Technology, Medical Devices, and Pharmaceutical Market Research, with 5+ years of experience in market research and industry analysis. His research on the Smart Drug Delivery Systems Market reve...
April 21, 2026
Multiomics is highly essential in drug discovery because of its advantage in developing precision medicine. North America is dominating the multiomics in drug discovery market because of growing investment in biotechnology industry....
July 23, 2026
According to our projections, the bulk-drug compounding market was valued at USD 12.52 billion in 2025 and reached USD 13.18 billion in 2026, and it is projected to grow to USD 20.87 billion by 2035 at a CAGR of 5.24% during 2026–2035....
July 22, 2026
AI in Drug Repurposing Market (By Product Type: AI Platforms & Software Suites, Database & Knowledge Graph Systems, Cloud-based Discovery Workbenches, AI-driven Screening Tools & Algorithms, Services, Others; By Technology: Machine Learni...
April 21, 2026
Around the world, the sex-based drug development market is driven by the rising approaches to sex-based differences, like pharmacokinetic, pharmacodynamic, and hormonal characteristics. Whereas, North America dominated the global market, with a growi...
June 16, 2026
According to Shivani Zoting, who specializes in Healthcare IT, Biotechnology, and Life Sciences market research, with 5+ years of experience in market research and industry analysis. Her research on the Drug Discovery Informatics Market highlights st...
April 21, 2026
Cell Dissociation Market (By Product: Enzymatic Dissociation, Non-enzymatic dissociation, Instruments & Accessories; By Type: Tissue Dissociation, Cell Detachment; By End-use: Pharmaceutical & Biotechnology Companies, Research & Academic ...
April 21, 2026
Market insights predict, the drug-device combination products industry is expected to grow from USD 161.78 billion in 2024 to USD 337.81 billion by 2034, driven by a CAGR of 7.64%. The rising incidences of chronic disorders, demand for personalized m...
April 21, 2026
The computer-aided drug design (CADD) market is primarily driven by the increasing need for developing new drugs. The growing new drug discovery research and technological advancements drive the market. North America led the global market owing to th...
April 21, 2026
Based on market forecasts, the advanced drug delivery sector will expand from USD 245.64 billion in 2024 to USD 385.14 billion by 2034, experiencing a CAGR of 4.6%. In 2023, oral drug delivery led the market with a 48% share, while controlled release...
July 10, 2026
According to Rohan Patil, a senior market research analyst specializing in pharmaceuticals and biopharmaceutical manufacturing with 5+ years of experience in market research and industry analysis, the Commercial Drug Manufacturing Market shows steady...
July 16, 2026
Projections indicate that, the global generative AI in drug discovery market will increase from USD 405.90 million in 2026 to USD 3593.80 million by 2035, experiencing a CAGR of 27.42% over the next 10 years. The generative AI in drug discovery marke...
July 20, 2026
According to Payal Rabde, who specializes in Target identification and validation, lead optimization and candidate selection, and high-throughput screening, with 4+ years of experience in market research and industry analysis, extensive research indi...
April 21, 2026
According to market projections, the global drug-eluting balloon catheters market, valued at USD 1.42 billion in 2024, is anticipated to reach USD 4.02 billion by 2034, growing at a CAGR of 11.1% over the next decade. The increasing cases of cardiova...
April 21, 2026
Market insights predict the global cell signaling industry will increase from USD 6.58 billion in 2024 to USD 14.11 billion by 2034, achieving a CAGR of 7.92%. Growing research and development in healthcare is promoting the use of cell signaling....
July 07, 2026
According to Rohan Patil, who specializes in the therapeutic area with 5+ years of experience in pharmaceutical industry analysis, extensive research indicates strong growth opportunities in the clinical trial drug sourcing market. The global c...
July 22, 2026
Market insights predict the U.S. drug utilization management industry will increase from USD 42.80 billion in 2025 to USD 88.45 billion by 2035, achieving a CAGR of 7.53%.The growing demand for personalized care and drug safety, and favorable governm...
July 29, 2026
According to market forecast, the global AI and ML in drug development market size was estimated at USD 3.84 billion in 2025 and is predicted to increase from USD 4.9 billion in 2026 to approximately USD 43.94 billion by 2035, expanding at a CAGR of ...
April 21, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 21.5 billion in 2024 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding d...
April 21, 2026
Projections indicate that, the global ankylosing spondylitis market will increase from USD 6.7 billion in 2025 to USD 11.83 billion by 2035, experiencing a CAGR of 5.85% over the next 10 years. The rising prevalence of autoimmune disorders and growin...
April 07, 2026
Drug Discovery Market ( By Functional Workflow/Stage: Hit identification, Target discovery & validation, Hit-to-lead & lead optimization, Biologics discovery, Preclinical candidate selection & IND-enabling studies, Translational & bio...
July 21, 2026
According to forecasts, the global intranasal drug delivery devices market will grow from USD 1.91 billion in 2025 to USD 4.98 billion by 2035, with an expected CAGR of 10.04%. The intranasal drug delivery devices market is growing as it provides rap...
July 06, 2026
According to Rohan Patil, who specializes in artificial intelligence in healthcare, pharmaceutical innovation, and life sciences, with 5+ years of experience in market research and industry analysis, the AI in Drug Discovery Market is entering a phas...
April 21, 2026
Market insights predict, the investigational new drug CDMO industry is expected to grow from USD 5.66 billion in 2025 to USD 11.10 billion by 2035, driven by a CAGR of 6.97%. The investigational new drug CDMO market is expanding due to increasing dev...
April 21, 2026
According to market projections, the therapeutic drug monitoring (TDM) sector is expected to grow from USD 1.92 billion in 2024 to USD 2.8 billion by 2034, reflecting a CAGR of 3.84%. Globally, the rising prevalence of chronic diseases, along with th...
April 21, 2026
Based on market forecasts, the global drug discovery platforms market, projected at USD 186.24 million in 2024, is expected to reach USD 635.45 million by 2034, growing at a CAGR of 13.44% over the forecast period. Drug discovery platforms use smart ...
April 29, 2026
Drug Delivery Nanoparticles Formulation Market (By Nanoparticle Type: Lipid-Based Nanoparticles, Polymeric Nanoparticles, Inorganic Nanoparticles, Dendrimers, Carbon-Based Nanoparticles; By Drug Type: Small Molecules, Biologics, Nucleic Acid-Based Dr...
April 21, 2026
According to forecasts, the global lipid nanoparticle raw materials market will grow from USD 300.72 million in 2025 to USD 522.01 million by 2035, with an expected CAGR of 5.67%. The need for better drug delivery systems for enhanced performance dri...
April 30, 2026
Drug Delivery CDMO Services Market (By Service Type: Development Services, Manufacturing Services, Packaging Services, Others (e.g., Regulatory Affairs); By Drug Type: Small Molecule Drugs, Biologics, Others; By End-user: Pharmaceutical Companies, Bi...
April 21, 2026
Based on market forecasts, the originator drug sector will expand from USD 24.54 billion in 2024 to USD 50.05 billion by 2034, experiencing a CAGR of 7.44%.The originator market is growing due to rising research in drug development. North America&r...
February 17, 2026
According to our forecasts, the drug delivery CDMO market is set for strong growth from 2026 to 2035, driven by rising chronic diseases, expanding biologics and GLP-1 therapies, and increasing outsourcing by pharmaceutical and biotech companies....
May 08, 2026
Biopharmaceutical Excipients Market (By Product Type: Organic Chemical, Inorganic Chemicals; By Functionality: Stabilizers, Solubilizers & Surfactants, Preservatives, Buffers, Bulking Agents, Others; By Formulation: Oral Formulations, Parenteral ...
April 10, 2026
Biotechnology and Pharmaceutical Services Outsourcing Market (By Service: Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education, Others; By End Use: Pharmaceutical Com...
April 21, 2026
Advantages of ML in drug discovery, including raised efficiency and prediction rates, are accelerating the drug discovery process as growing cases of various diseases are fueling the expansion of the market across the world. Whereas North America dom...
April 14, 2026
Pharmaceutical Hot Melt Extrusion Market (By Type: Twin-Screw Extruder, Single-Screw Extruder; By Application:Pharma Companies, Contract Manufacturing Organizations (CMOs), Research Laboratories, Others;By Dosage Form: Solid Dosage Forms, Semi-Solid/...
April 21, 2026
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing stro...
May 20, 2026
Drug Desensitization Market (By Therapy Type: Sublingual Immunotherapy, Subcutaneous Immunotherapy, Oral and Other Delivery Methods; By Drug Class: Antibiotics, Chemotherapy Agents, Monoclonal Antibodies, NSAIDs and Others; By End-User: Hospitals and...
April 21, 2026
Expansion of healthcare facilities, especially in emerging economies, is improving access to advanced cancer treatments, further supporting market expansion. North America has a robust healthcare system with significant spending on advanced treatme...
February 27, 2026
Our projections indicate that, the antibody-drug conjugates (ADCs) CMO and CDMO market was valued at USD 9.93 billion in 2025 and reached USD 11.08 billion in 2026, and it is projected to grow to USD 29.65 billion by 2035, expanding at a CAGR of 11.5...
April 21, 2026
Market insights predict the global antibiotic-coated surgical implant drug industry will increase from USD 1.17 billion in 2024 to USD 3.05 billion by 2034, achieving a CAGR of 10.05%. The increasing number of surgeries and the rising prevalence of...
July 20, 2026
Cell and Gene Therapy Drug Delivery Devices Market ( By Product / Device Type: Infusion Systems & Pumps, Prefilled Syringes & Vials, Autoinjectors & Wearable Injectors, Apheresis & Collection Kits / Administration Kits, Closed System ...
April 21, 2026
According to market projections, the global bio-based propylene glycol market, valued at USD 289.25 million in 2024, is anticipated to reach USD 837.57 million by 2034, growing at a CAGR of 11.25% over the next decade. The growing new drug discovery ...
April 21, 2026
The drug discovery SaaS platforms market is growing as mainly used in the drug discovery process for virtual screening, data management and analysis, AI-powered drug design, facilitating collaboration, clinical trial optimization, drug repurposing, t...
April 21, 2026
Projections indicate that, the global bronchitis treatment market will increase from USD 6.85 billion in 2024 to USD 11.45 billion by 2034, experiencing a CAGR of 5.28% over the next 10 years. The market is driven by growing COPD cases (due to air po...
April 21, 2026
The market is growing due to increasing globalization of trade and rising demand for efficient, technology-driven logistics solutions. Digitalization and automation are further enhancing speed, transparency, and cost-effectiveness in supply chain ope...
April 21, 2026
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
April 21, 2026
Market insights predict, the drug discovery as a service industry is expected to grow from USD 21.3 billion in 2024 to USD 79.82 billion by 2034, driven by a CAGR of 14.17%. The drug discovery as a service market is expanding due to increasing cancer...
April 21, 2026
According to market estimations, the molecular interaction analyzer sector size to capture US$ 337.7 million in 2025 is to soar US$ 454.1 million by 2030. The molecular interaction analyzer market is driven by increasing demand for proteomics researc...
April 21, 2026
According to market estimations, the global thrombopoietin receptor agonists industry, valued at US$ 1.85 billion in 2023, is set to reach US$ 3.74 billion by 2034, driven by rising platelet-related disorders like ITP and AML. Key trends include FD...
April 21, 2026
According to market projections, the radiation-induced dermatitis drug sector is expected to grow from USD 510 million in 2024 to USD 729.2 million by 2034, reflecting a CAGR of 3.64%. The growing need for radiation therapy and the increasing develop...
April 21, 2026
Based on market forecasts, the life science chemical biotech instrumentation sector will expand from USD 34.23 billion in 2024 to USD 50.85 billion by 2034, experiencing a CAGR of 4.05%. The growing research and development activities and technologic...
July 22, 2026
According to Payal Rabde, who specializes in biotechnology formulations, microfluidic devices, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth oppo...
April 21, 2026
Based on market forecasts, the global syphilis testing market, projected at USD 2.29 billion in 2024, is expected to reach USD 4.57 billion by 2034, growing at a CAGR of 6.85% over the forecast period. The market is expanding due to the global increa...
April 21, 2026
Market insights predict, the diagnostic testing industry is expected to grow from USD 203.3 billion in 2024 to USD 274.53 billion by 2034, driven by a CAGR of 3.04%. The rising prevalence of chronic and infectious diseases is estimated to drive the g...
July 14, 2026
According to Shivani Zoting, who specializes in advanced cancer diagnostics solutions, liquid-based genomic testing, and non-invasive molecular diagnostics, with 5+ years of experience in market research and industry analysis, extensive research indi...
January 27, 2026
Based on our market forecasts, the early toxicity testing sector will expand from USD 1.34 billion in 2025 to USD 2.72 billion by 2035, experiencing a CAGR of 7.34%. The early toxicity testing market is expanding rapidly, driven by its role in safety...
July 10, 2026
According to Rohan Patil, who specializes in biological contamination assessment, quality control for biologics, bacterial endotoxins, and sterility and pyrogen detection with 5+ years of experience in market research and industry analysis, extensive...
April 21, 2026
Market insights predict the global genomic urine testing industry will increase from USD 148.23 million in 2024 to USD 319.14 million by 2034, achieving a CAGR of 7.94%. The genomic urine testing market is growing due to its enhanced ability to predi...
January 22, 2026
According to our insight, the U.S. antibody specificity testing market was valued at USD 343.71 million in 2025 and is projected to grow from USD 369.18 million in 2026 to nearly USD 702.49 billion by 2035, expanding at a CAGR of 7.41% during the for...
April 21, 2026
According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of p...
January 09, 2026
According to forecasts, the global PFAS testing market will grow from USD 537.89 million in 2025 to USD 2090.58 million by 2035, with an expected CAGR of 14.54%. Across the globe, the market is fueled by escalating awareness of PFAS's potential healt...
January 08, 2026
Based on market forecasts, the DNA polymerase sector will expand from USD 419.87 million in 2025 to USD 769.12 million by 2035, experiencing a CAGR of 6.24%.The DNA polymerase market is expanding due to growing demand for diagnostic applications as w...
January 07, 2026
Our projections indicate that, pharma nitrosamine testing industry is projected to rise from USD 157.9 million in 2025 to USD 300.32 million by 2035, reflecting a CAGR of 6.64% over the next decade. The pharma nitrosamine testing market is growing ...
January 29, 2026
Based on market forecasts, the global infectious disease testing market, projected at USD 29.04 billion in 2025, is expected to reach USD 53.19 billion by 2035, growing at a CAGR of 6.24% over the forecast period. The infectious disease testing marke...
July 20, 2026
According to Payal Rabde, who specializes in blood coagulation, Percutaneous coronary intervention (PCI), and automated ACT, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunitie...
February 06, 2026
Based on our market research, the genetic stability testing service market covers a comprehensive assessment of global market size, valued at USD 1.48 billion in 2026 and projected to reach USD 3.28 billion by 2035, growing at a CAGR of 9.24% (2026&n...
April 21, 2026
Based on market forecasts, the non-invasive prenatal testing sector will expand from USD 6.45 billion in 2024 to USD 18.94 billion by 2034, experiencing a CAGR of 11.65%. The non-invasive prenatal testing market is growing due to the increasing deman...
July 27, 2026
Market insights predict, the direct-to-consumer genetic testing industry is expected to grow from USD 3.05 billion in 2025 to USD 27.15 billion by 2035, driven by a CAGR of 24.44%. The direct-to-consumer genetic testing market is expanding due to inc...
January 13, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the to...
July 24, 2026
According to forecasts, the global bio burden testing market will grow from USD 1.77 billion in 2025 to USD 6.82 billion by 2035, with an expected CAGR of 14.44%.The global market is fueled by stringent regulatory guidelines for product safety and qu...
July 17, 2026
Based on market forecasts, the residual DNA testing sector will expand from USD 348.06 million in 2026 to USD 586.04 million by 2035, experiencing a CAGR of 5.96%. The residual DNA testing market is rising due to strict regulations to ensure patient ...
April 21, 2026
Market insights predict the global button-activated safety lancet industry will increase from USD 761.19 million in 2025 to USD 2351.51 million by 2035, achieving a CAGR of 11.94%. The rising prevalence of diabetes and the growing demand for point-of...
April 21, 2026
According to market projections, the global extractable and leachable testing services market, valued at USD 1.12 billion in 2024, is anticipated to reach USD 4.6 billion by 2034, growing at a CAGR of 15.17% over the next decade. The growing pharmace...
July 23, 2026
According to Payal Rabde, who specializes in detecting and quantifying residual host cell DNA, quality control and release testing, advanced molecular techniques, FDA, EMA, WHO, and ICH, and improving product quality and patient safety, with 4+ yea...
July 17, 2026
According to market projections, the pharmaceutical testing services sector is expected to grow from USD 4.72 billion in 2025 to USD 12.86 billion by 2035, reflecting a CAGR of 10.54%.Due to accelerating heavy investments in R&D and demand for bi...
July 14, 2026
According to Rohan Patil, who specializes in cell therapy bioanalytical testing services, viral vector testing and characterization, and immunogenicity testing services with 5+ years of experience in market research and industry analysis, extensive r...
July 28, 2026
According to Payal Rabde, who specializes in rapid detection of microorganisms, pharmaceutical sterility testing, bioburden testing, and medical device microbiological testing, with 4+ years of experience in market research and industry analysis, ext...
July 08, 2026
Medical Device Testing Market (By Service: Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Test; By Phase: Preclinical, Clinical; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global Analy...
April 23, 2026
Sickle Cell Anemia Testing and Screening Market ( By Technology: Hemoglobin Electrophoresis, High-Performance Liquid Chromatography, Other Tests; By Age Group: Newborn Screening, Adult Screening, Other Age Groups; By Sector Type: Government Labs, Pri...
April 15, 2026
Bioanalytical Testing Services Market (By Molecule: Small Molecule, Large Molecule; By Test: Bioavailability, Bioequivalence, ADME, Pharmacokinetics, Pharmacodynamics, Biomarker Testing, Cell-based Assay, Virology Testing, Other Tests; By Workflow: S...
July 15, 2026
According to market projections, the global microbiology testing market, valued at USD 6.95 billion in 2026, is anticipated to reach USD 15.14 billion by 2035, growing at a CAGR of 9.04% over the next decade. Microbial testing is a highly essential p...
July 17, 2026
According to market projection, the C-reactive protein testing market is set for steady growth, increasing from USD 5.62 billion in 2026 to approximately USD 5.77 billion by 2035. Her analysis identifies immunoturbidimetric assays, hs-CRP testing, ca...
July 10, 2026
According to Rohal Patil, who specializes in the pharmaceutical industry research, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the API stability testing services ma...
May 28, 2026
Pulmonary Function Testing Systems Market (By Type: Spirometers, Peak Flow Meters, Gas Analyzers, Oximeters, Others; By End-User: Hospitals, Clinics, Home Care, Ambulatory Surgical Centers (ASCs); By Application: Chronic Obstructive Pulmonary Disease...
March 18, 2026
Our projections indicate that, the pharmaceutical microbiology QC testing market report provides a comprehensive analysis of global industry trends, covering market size estimated at USD 4.6 billion in 2026 and projected to reach USD 13.84 billion by...
February 03, 2026
According to forecasts, the global endocrine testing market will grow from USD 3.25 billion in 2025 to USD 7.36 billion by 2034, with an expected CAGR of 8.54%. With more individuals proactively monitoring their health, the endocrine testing market i...
July 21, 2026
Projections indicate that, direct-to-consumer laboratory testing industry is projected to rise from USD 4.12 billion in 2026 to USD 8.90 billion by 2035, reflecting a CAGR of 8.94% over the next decade. The market is growing due to increasing consume...
April 21, 2026
Market insights predict, the rapid medical diagnostic kits industry is expected to grow from USD 28.12 billion in 2025 to USD 67 billion by 2035, driven by a CAGR of 9.07%. In 2024, North America led the rapid medical diagnostic kits market with a 37...
April 24, 2026
Point of Care Infectious Disease Testing Market (By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through test/Immunoconcentration Assay, Molecular Diagnostics; Others By Disease: HIV POC, Clostridium Difficile POC, HBV POC, Pneumoni...
April 21, 2026
Market insights predict the global in vitro release testing (IVRT) industry will increase from USD 65.55 million in 2024 to USD 252.64 million by 2034, achieving a CAGR of 14.47%.The market is growing due to rising demand for bioequivalent testing ...
April 21, 2026
According to projections, the global microbial testing service market was estimated at US$ 6.39 billion in 2025 and is projected to grow to US$ 9.89 billion by 2030. The microbial testing service market is expanding due to rising infectious diseases ...
April 21, 2026
Projections indicate that, the global biological safety testing market will increase from USD 5.43 billion in 2024 to USD 15.07 billion by 2034, experiencing a CAGR of 10.75% over the next 10 years. The Growing concern regarding the safety of product...
July 23, 2026
According to Payal Rabde, who specializes in diagnostic testing services, medical imaging services, cardiovascular diagnostic tests, and pulmonary function testing, with 4+ years of experience in market research and industry analysis, extensive resea...
April 21, 2026
Market insights predict the global liquid biopsy IVD industry will increase from USD 2.21 billion in 2024 to USD 8.72 billion by 2034, achieving a CAGR of 14.79%. The liquid biopsy IBD market is growing due to the rising cases of cancer. North Amer...
July 16, 2026
Market insights predict, the biologics safety testing industry is expected to grow from USD 5.20 billion in 2026 to USD 16.45 billion by 2035, driven by a CAGR of 13.64%. The growing demand for biologics and growing research and development activitie...
April 21, 2026
Based on market forecasts, the point-of-care molecular diagnostics sector will expand from USD 4.05 billion in 2024 to USD 11.03 billion by 2034, experiencing a CAGR of 10.45%. The point-of-care molecular diagnostics market is expanding due to incr...
April 21, 2026
Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the ...
April 21, 2026
According to market projections, the global host cell protein testing market, valued at USD 2.37 billion in 2024, is anticipated to reach USD 5.19 billion by 2034, growing at a CAGR of 8.17% over the next decade. The growing demand for biologics and ...
January 23, 2026
According to our projections, the acne drugs market is comprehensively analyzed covering global market size valued at USD 10.78 billion in 2026 and projected to reach USD 17.07 billion by 2035, growing at a CAGR of 5.24%...
April 21, 2026
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
April 21, 2026
According to market projections, the pain management drugs sector is expected to grow from USD 84.1 billion in 2024 to USD 126.17 billion by 2034, reflecting a CAGR of 4.14%. The rising prevalence of chronic pain and growing research and development ...
February 26, 2026
According to market projections, the nucleic acid drugs sector is expected to grow from USD 57.03 million in 2025 to USD 348.45 million by 2035, reflecting a CAGR of 19.84%. The nucleic acid drugs market is expanding due to advances in delivery techn...
April 21, 2026
Market insights predict, the antitumor ADC drugs industry is expected to grow from USD 7.38 billion in 2025 to USD 24.75 billion by 2035, driven by a CAGR of 12.86%. Rising cancer incidence/unmet needs have driven the growth of the market. North Amer...
April 21, 2026
Projections indicate that, hyperkalemia drugs industry is projected to rise from USD 1.42 billion in 2025 to USD 5.20 billion by 2035, reflecting a CAGR of 13.84% over the next decade. The market is growing due to the rising prevalence of chronic kid...
April 21, 2026
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susce...
April 21, 2026
Market insights predict the global cancer supportive care drugs industry will increase from USD 21.89 billion in 2024 to USD 27.05 billion by 2034, achieving a CAGR of 2.14%. The increased focus on the prevention and management of the adverse effects...
April 02, 2026
Veterinary Ophthalmic Drugs Market (By Drug Class: Anti-infectives, Anti-inflammatory drugs, Anti-glaucoma drugs, Lubricants & artificial Tears, Others; By Animal Type: Companion Animals, Livestock Animals; By Indication: Conjuctivities, Keratiti...
April 21, 2026
Based on market forecasts, the biosynthesis peptide drugs sector will expand from USD 18.31 billion in 2024 to USD 32.88 billion by 2034, experiencing a CAGR of 6.26%. The biosynthesis peptide drugs market is growing, as these drugs offer many advant...
June 17, 2026
According to Rohan Patil, who specializes in Pharmaceutical Market Research and Healthcare Industry Analysis, with 5+ years of experience in market research and industry analysis. His research indicates that the global genitourinary drugs market is p...
April 21, 2026
According to market projections, the hyperlipidemia drugs sector is expected to grow from USD 24.47 billion in 2025 to USD 31.49 billion by 2034, reflecting a CAGR of 2.84%. In 2024, North America led the global hyperlipidemia drugs market, with stat...
April 21, 2026
Based on market forecasts, the global gastrointestinal drugs market, projected at USD 40.21 billion in 2024, is expected to reach USD 55.85 billion by 2034, growing at a CAGR of 3.34% over the forecast period. The gastrointestinal drugs market is gro...
July 13, 2026
Drugs Market ( By Product Type: Prescription Drugs Over-the-Counter (OTC) Drugs; By Therapeutic Area: Oncology, Cardiovascular, Central Nervous System, Respiratory, Infectious Diseases, Gastrointestinal, Diabetes, Autoimmune Disorders, Dermatology, O...
April 21, 2026
According to forecasts, the global respiratory drugs market will grow from USD 17.53 billion in 2024 to USD 30.81 billion by 2034, with an expected CAGR of 5.8%. In 2023, COPD was the most common respiratory disorder, leading the market with a 36% sh...
July 31, 2026
According to market projections, the generic drugs industry is expected to grow from USD 513.02 billion in 2025 to USD 859.84 billion by 2035, driven by a CAGR of 5.3%, driven by the need to reduce healthcare costs. North America leads the market, wh...
July 14, 2026
According to Rohan Patil, who specializes in acute sinusitis treatment, chronic sinusitis management, and nasal inflammation control, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opp...
April 21, 2026
According to market projections, the global insulin drugs and delivery devices market, valued at USD 23.75 billion in 2024, is anticipated to reach USD 49.18 billion by 2034, growing at a CAGR of 7.65% over the next decade. The rising prevalence of d...
April 21, 2026
According to market projections, the global 3D printed drugs market, valued at USD 131.25 million in 2025, is anticipated to reach USD 547.36 million by 2035, growing at a CAGR of 15.35% over the next decade. In 2024, North America led the 3D printed...
April 21, 2026
According to market projections, the global antipyretic and analgesic drugs market, valued at USD 47.47 billion in 2024, is anticipated to reach USD 77.99 billion by 2034, growing at a CAGR of 5.09% over the next decade. The rising prevalence of feve...
April 21, 2026
Market insights predict, the epilepsy drugs industry is expected to grow from USD 9.98 billion in 2024 to USD 16.42 billion by 2034, driven by a CAGR of 5.1%. Epilepsy drugs help control seizures by stabilizing brain activity. They work by reducing e...
April 21, 2026
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital ...
July 24, 2026
According to forecasts, the global asthma and COPD drugs market will grow to USD 70.27 billion by 2035, with an expected CAGR of 5.01%. In 2024, King's College London showed that benralizumab can reduce hospitalizations in severe asthma and treat ast...
April 30, 2026
Migraine Drugs Market (By Treatment: Acute, Preventive; By Therapeutic Class: CGRP monoclonal antibodies, CGRP small molecule antagonists, Acetylcholine inhibitors/ neurotoxins, Triptans, Ditans, Ergot alkaloids, NSAIDs, Others; By Route of Administr...
April 21, 2026
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023,...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
July 06, 2026
Market insights predict the global pediatric drugs industry will increase from USD $182.39 billion in 2026 to USD $513.98 billion by 2035, achieving a CAGR of 12.2%. Pediatric drugs are medicines specially designed for children to treat illnesse...
July 16, 2026
According to Shivani Zoting, who specializes in pharmaceutical and biotechnology market research, with 5+ years of experience in market research and industry analysis. My research indicates that the Psychedelic Drugs Market is set to grow from USD 6....
July 23, 2026
According to our market projection, the global brain tumor drugs market size was estimated at USD 2.33 billion in 2025 and is predicted to increase from USD 2.55 billion in 2026 to approximately USD 5.69 billion by 2035, expanding at a CAGR of 9.34% ...
April 21, 2026
The chemical synthesis peptide drugs market is valued at US$ 2.74 billion in 2025 and is projected to reach US$ 4.82 billion by 2034, growing at a CAGR of 6.54%. Key segments include synthesis methods (chemical, non-chemical), technologies (SPPS, LPP...
April 21, 2026
According to forecasts, the global cardiovascular drugs market will grow from USD 150.02 billion in 2024 to USD 213.36 billion by 2034, with an expected CAGR of 3.65%. The cardiovascular drugs market is expanding due to growing early diagnosis as wel...
July 17, 2026
According to market projections, the GLP-1 drugs sector is expected to grow from USD 52.95 billion in 2025 to USD 132.79 billion by 2035, reflecting a CAGR of 9.63%. The GLP-1 drugs market is expanding due to increasing incidences of type 2 diabetes ...
April 21, 2026
AI in clinical trials for drugs market is growing due to its use in clinical research to monitor and improve medication adherence. This is particularly through the use of applications, such as facial, digital biomarkers, and vocal expression. AI redu...
July 06, 2026
According to market projections, the diabetes drugs sector is expected to grow from USD 75.16 billion in 2025 to USD 143.76 billion by 2035, reflecting a CAGR of 6.7%. The diabetes drugs market is growing due to the rising global prevalence of diabet...
July 06, 2026
The anesthesia drugs market size is calculated at USD 0.76 bn in 2026 is to hit USD 2.33 bn by 2035. The anesthesia drugs market is growing due to rising surgical procedures, advancements in anesthesia techniques, and increasing demand for outpatient...
July 14, 2026
According to Rohan Patil, who specializes in treatment for viral infectious diseases, broad-spectrum antiviral therapeutics, and pediatric and adult antiviral treatment, with 5+ years of experience in market research and industry analysis, extensive ...
April 21, 2026
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are ...
July 09, 2026
Projections indicate that, the global anti-obesity drugs market will increase from USD 9.11 billion in 2025 to USD 99.74 billion by 2035, experiencing a CAGR of 27.04% over the next 10 years. In 2024, North America led the anti-obesity drugs market, ...
January 13, 2026
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 19.55 billion in 2025 to USD 30.65 billion by 2035, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage b...
April 21, 2026
According to market projections, the U.S. pain management drugs sector is expected to grow from USD 31.84 billion in 2024 to USD 44.92 billion by 2034, reflecting a CAGR of 3.64%. The U.S. pain management drugs market is growing due to rising cases o...
April 21, 2026
Projections indicate that, anti-inflammatory drugs industry is projected to rise from USD 122.32 billion in 2024 to USD 274.79 billion by 2034, reflecting a CAGR of 8.43% over the next decade. In 2024, North America led the anti-inflammatory drugs ma...
July 29, 2026
According to Shivani Zoting, who specializes in pharmaceuticals and healthcare market research, with 5+ years of experience in market research and industry analysis. Her research indicates that the global Over the Counter (OTC) Drugs Market is projec...
April 21, 2026
According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophreni...
July 20, 2026
Based on market forecasts, the global ophthalmology drugs market, projected at USD 45.52 billion in 2025, is expected to reach USD 76.51 billion by 2035, growing at a CAGR of 5.33% over the forecast period. The ophthalmology drugs market is growing d...
July 06, 2026
According to market projections, the global liver cancer drugs market, valued at USD 3.97 billion in 2026, is anticipated to reach USD 13.13 billion by 2035, growing at a CAGR of 14.2% over the next decade. Liver cancer drugs are medicines used...
April 21, 2026
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
April 21, 2026
Market insights predict the global inhalation and nasal spray generic drugs industry will increase from USD 25.18 billion in 2025 to USD 59.35 billion by 2035, achieving a CAGR of 8.99%. The inhalation and nasal spray generic drugs market is expandin...
April 21, 2026
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
April 21, 2026
Based on market forecasts, the targeted drugs for allergic diseases sector will expand from USD 13.96 billion in 2024 to USD 30.22 billion by 2034, experiencing a CAGR of 8.06%. The targeted drugs for allergic diseases market is growing due to rising...
May 28, 2026
North America Asthma and COPD Drugs Market (By Drug Class: Bronchodilators, Anti-Inflammatory Drugs, Combination Drugs, Biologics, Other Drugs; By Disease Type: Asthma, COPD, Asthma-COPD Overlap Syndrome (ACOS); By Distribution Channel: Hospital Phar...
April 30, 2026
According to Rohan Patil, who specializes in drug therapies, disease management solutions, and cardiovascular risk reduction therapies, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth o...
July 09, 2026
The organ transplant immunosuppressant drugs market size is calculated at USD 6.09 bn in 2026 is to hit USD 9.23 bn by 2035. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diab...
April 21, 2026
According to market projections, the antimalarial drugs sector is expected to grow from USD 1.07 billion in 2024 to USD 1.67 billion by 2034, reflecting a CAGR of 4.57%. Establishing awareness and government programs are propelling the global market ...
July 08, 2026
According to Shivani Zoting, who specializes in pharmaceuticals and healthcare market research, with 5+ years of experience in market research and industry analysis, the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is set for steady expansio...
April 21, 2026
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing du...
February 20, 2026
Based on our estimations, the intravenous iron drugs market was valued at USD 3.65 billion in 2025 and reached USD 3.98 billion in 2026, and is projected to grow to USD 8.74 billion by 2035, expanding at a CAGR of 9.14% (2026–2035)....
April 21, 2026
According to forecasts, the global age-related macular degeneration (AMD) drugs market will grow from USD 10.57 billion in 2024 to USD 29.04 billion by 2034, with an expected CAGR of 10.66%. Rising patient demand for a better quality of life is estim...
April 21, 2026
According to market projections, the pelvic inflammatory disease treatment sector is expected to grow from USD 3.52 billion in 2024 to USD 5.09 billion by 2034, reflecting a CAGR of 3.75%. In 2024, North America led the global pelvic inflammatory dis...
April 21, 2026
According to market estimations the global leuprorelin drugs market, valued at US$ 2.60 billion in 2023, is projected to reach US$ 4.78 billion by 2034, driven by rising cancer cases and gender-affirming surgeries. North America leads the market, w...
February 19, 2026
According to our forecasts, the invasive fungal disease (IFD) drugs market was valued at USD 3.11 billion in 2025 and is projected to grow from USD 3.29 billion in 2026 to USD 5.34 billion by 2035, expanding at a CAGR of 5.55% during 2026–2035....
April 21, 2026
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
April 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
+1 9197 992 333
+91 93077 85324
